Inovia Bio
Inovia Bio offers faster, more precise drug development using AI. It uses its InovaSight platform to provide evidence-based overviews of clinical results, trial data, market potential, and competitors. The company operates as a biotechnology business delivering reimagined drug development services to pharma and biotech clients. The solution sits in the B2B biotech and drug development space, leveraging AI to speed preclinical to launch processes.
Inovia Bio
Inovia Bio offers faster, more precise drug development using AI. It uses its InovaSight platform to provide evidence-based overviews of clinical results, trial data, market potential, and competitors. The company operates as a biotechnology business delivering reimagined drug development services to pharma and biotech clients. The solution sits in the B2B biotech and drug development space, leveraging AI to speed preclinical to launch processes.
TL;DR
What they do: AI-driven evidence and RWE platforms to accelerate drug development for pharma/biotech (B2B)
Founded: 2022
Headquarters: London
Team size: ~7 employees
Company Overview
Problem Domain
Drug development inefficiencies; need for faster, evidence-driven clinical development and regulatory alignment.
Founded
2022
Industry
Biotechnology